Skip to main content

Table 1 Demographic and clinical characteristics of the patients included in the study

From: Factors influencing failure to undergo interval cholecystectomy after percutaneous cholecystostomy among patients with acute cholecystitis: a retrospective study

  Interval cholecystectomy (n = 138) Non-interval cholecystectomy (n = 67) P-value
Age (years) 64.33 ± 14.61 73.40 ± 12.97  < 0.001
Sex    0.754
 Female 65 (47.10%) 30 (44.78%)  
 Male 73 (52.90%) 37 (55.22%)  
TG18 grade     < 0.001
 Grade I 95 (68.84%) 38 (56.72%)  
 Grade II 32 (23.19%) 10 (14.93%)  
 Grade III 11 (7.97%) 19 (28.36%)  
Laboratory test
 White blood cell (× 109/L) 12.20 (8.12–15.68) 10.16 (7.32–14.90) 0.956
 Direct bilirubin (μmol/L) 11.60 (6.10–19.50) 10.00 (5.47–46.92) 0.099
 Total bilirubin (μmol/L) 22.40 (13.60–37.90) 21.80 (11.50–61.70) 0.238
 Aspartate aminotransferase (U/L) 26.00 (18.00–53.00) 25.00 (17.00–53.00) 0.566
 Alanine aminotransferase (U/L) 26.00 (16.00–60.00) 23.00 (15.00–61.00) 0.164
 Serum creatinine (μmol/L) 69.20 (55.70–87.25) 69.30 (51.80–106.90) 0.494
 INR 1.22 ± 0.13 1.35 ± 0.80 0.096
 Platelet (× 109/L) 189.37 ± 68.98 183.49 ± 76.10 0.587
Albumin stratification (g/L)    0.004
 > 35 42 (41.58%) 11 (24.44%)  
 28–35 50 (49.50%) 21 (46.67%)  
 < 28 9 (8.91%) 13 (28.89%)  
Image performance
 Gallbladder distention (> 4 cm) 129 (93.48%) 65 (97.01%) 0.292
 Thickened gallbladder wall (> 3 mm) 135 (97.83%) 64 (95.52%) 0.359
 Gallstones 118 (85.51%) 41 (63.08%)  < 0.001
 Common bile duct stones 27 (19.57%) 14 (21.54%) 0.744
 Common bile duct dilatation (> 6 mm) 34 (24.64%) 17 (25.37%) 0.909
 Pericholecystic effusion 70 (50.72%) 33 (49.25%) 0.843
Comorbidity
 Hypertension 48 (34.78%) 30 (44.78%) 0.167
 Diabetes 23 (16.67%) 14 (20.90%) 0.460
 Cardiovascular and cerebrovascular diseases 40 (28.99%) 34 (50.75%) 0.002
 History of malignancy 11 (7.97%) 18 (26.87%)  < 0.001
 Liver cirrhosis 2 (1.45%) 0 (0.00%) 0.322
 Kidney disease 4 (2.90%) 4 (5.97%) 0.287
Postoperative
 Septic shock 4 (2.90%) 4 (5.97%) 0.287
 Transfer to ICU 4 (2.90%) 2 (2.99%) 0.972
 Hospitalization days 7 (5–11) 6 (4–10) 0.713
PC-related complications 4 (2.90%) 5 (7.46%) 0.353
 Clogged tube 2 (1.45%) 1 (1.49%) 0.981
 Dislodged tube 2 (1.45%) 4 (5.97%) 0.072
Recurrence after PC 19 (13.77%) 15 (22.39%) 0.120
 All-cause deaths during follow-up 1 (0.72%) 19 (28.36%)  < 0.001